New combo therapy shows promise in kidney cancer fight
Disease control
Ongoing
This study tested two immunotherapy drugs, nivolumab and ipilimumab, in 85 adults with advanced kidney cancer that could not be removed by surgery. The goal was to see if adding ipilimumab could turn non-responding tumors into shrinking ones, and how long any response lasted afte…
Phase: PHASE2 • Sponsor: Toni Choueiri, MD • Aim: Disease control
Last updated May 15, 2026 11:57 UTC